Buprenorphine Treatment Centers in Tennessee

For buprenorphine, patients typically need to be in mild withdrawal before the first dose to avoid precipitated withdrawal. Methadone can be started without withdrawal, and naltrexone requires 7–14 opioid-free days. Your Tennessee provider will explain the induction protocol that applies to your medication.

It depends on the program. Bundled MAT programs include counseling in a single weekly or monthly fee. Others bill counseling separately ($40–$150 per session). TennCare and most commercial plans cover both components when delivered by a licensed provider.

No. Drug screens performed as part of an MAT program are covered by TennCare without an additional patient copay. The clinic bills TennCare directly; patients should not receive separate drug-screen bills.

Call the number on the back of your insurance card and ask: (1) Is {provider name} in-network? (2) What is my mental-health/MAT deductible? (3) What is my copay for MAT visits? Write the reference number from the call for any dispute later.

Yes. Tennessee hospitals routinely start buprenorphine in the ED and bridge patients to outpatient MAT. The state’s opioid-response plan funds ED warm-handoff coordinators who connect patients to buprenorphine providers in their home zip code before discharge.

Nationwide average MAT retention is about 6–18 months; the strongest outcomes occur in patients retained beyond 12 months. Tennessee State Opioid Response data reports rising average retention since 2021 as hub-and-spoke models mature.

Many Tennessee OTPs and low-barrier clinics accept walk-ins during intake hours. Others require an appointment; call first to confirm. Walk-in availability is most common at federally qualified health centers and State Opioid Response–funded bridge clinics.

Usually yes. Tennessee programs following low-barrier protocols provide the first buprenorphine dose or naltrexone prescription on day one. Methadone first doses are administered in-clinic and require SAMHSA-certified protocols that are typically completed during the intake visit.

Common side effects are usually mild and transient: nausea, constipation, headache, drowsiness, sweating, and insomnia. Most resolve within 1–2 weeks of dose stabilization. Persistent side effects are addressed by dose adjustment or switching medications at your Tennessee clinic.

Naltrexone is typically not started during pregnancy due to limited safety data — methadone or buprenorphine are preferred. Patients already stable on naltrexone who become pregnant discuss continuing versus switching with their Tennessee MAT provider and obstetrician.

Sessions cover craving management, relapse-prevention skills, coping strategies, relationship issues, trauma processing if relevant, and goal setting for recovery. The counselor and client collaborate on a written treatment plan that is updated every 30–90 days in Tennessee.

Buprenorphine and naltrexone prescriptions appear on pharmacy records like other prescriptions and are visible to dispensing pharmacies and authorized users of the PDMP. Methadone dispensed at an OTP is not reported to retail pharmacy systems.